EXPLORING THE ROLE OF CLINICAL PHARMACIST INTERVENTION ON THE OUTCOMES OF PATIENTS WITH TYPE 2 DIABETES MELLITUS

Zheen Aorahman Ahmed a, Zhwan Azad Abdallah b, and Tavga Ahmed Aziz b


Department of Pharmacology & Toxicolog, College of Pharmacy, University of Sulaimani, Kurdistan Region, Iraq.
b Department of Clinical Pharmacy, College of Pharmacy, University of Sulaimani, Kurdistan Region, Iraq. 

 

Submitted: 6/2/2020; Accepted: 1/12/2020; Published: 21/12/2020
ABSTRACT


Background 

Diabetes mellitus has been commonly identified as a metabolic disorder characterized by hyperglycemia that occurs as a result of insulin secretion deficiencies, insulin action, or both. It is the fourth largest cause of death, researches aimed to define and compare the views of pharmacists of type 2 diabetes mellitus about causes and methods that improves quality of life and consistency to medication. In order to obtain better therapeutic outcomes by decreasing medicine-related issues it needs to work closely with the patient in implementing and tracking therapeutic plans.


Objectives 

The present study was aimed to evaluate the role of clinical pharmacist interventions in improving the outcome of patients with type 2 diabetes mellitus.


Methods

The study was conducted between December 2018 to April 2019 at the Center of Diabetes and Endocrine disease, Directory of Health/ Sulaimani city. One hundred and twenty patients with type 2 diabetes mellitus were randomly divided into two groups: Conventional group that received the usual care and interventional group that received the clinical pharmacist intervention including patient education on life style modification and general guidance on drug therapy that aimed to improve patients’ quality of life and decrease the cost on the diabetic center. Blood sample collected from each patient at zero time and after 90 days of measuring fasting blood glucose, glycosylated hemoglobin and insulin level.


Results

Clinical pharmacist intervention resulted in a significant decrease in body weight, waist circumference and body mass index with no significant change in visceral adiposity index after three months intervention compared to baseline value. It also significantly decreased fasting blood glucose, glycosylated hemoglobin, serum insulin level, and insulin resistance when compared with the baseline value and the conventional group at the end of the study. The interventional group showed reduction in frequency of negative impacts of diabetes mellitus when compared to the baseline value and the conventional group, the intervention also resulted in decreased the cost on the diabetic center.


Conclusion

The implementation of diabetic self-care intervention by the pharmacist was effective in improving glycemic status, and body weight. The intervention also caused reduction in frequency of negative impacts of diabetes mellitus eventually initiated reduction in the overall healthcare cost of diabetic patients compared to patients received usual care.



KEYWORDS

Type 2 Diabetes mellitus; Clinical pharmacist intervention; Glycemic status; Quality of life; Cost-effectiveness.